BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17124342)

  • 1. Biomarkers in multiple sclerosis: role of antibodies.
    Berger T; Reindl M
    Dis Markers; 2006; 22(4):207-12. PubMed ID: 17124342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers for multiple sclerosis.
    Lutterotti A; Berger T; Reindl M
    Curr Med Chem; 2007; 14(18):1956-65. PubMed ID: 17691938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies as biological markers for pathophysiological processes in MS.
    Reindl M; Khalil M; Berger T
    J Neuroimmunol; 2006 Nov; 180(1-2):50-62. PubMed ID: 16934337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
    Berger T; Reindl M
    J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
    Carotenuto A; D'Ursi AM; Mulinacci B; Paolini I; Lolli F; Papini AM; Novellino E; Rovero P
    J Med Chem; 2006 Aug; 49(17):5072-9. PubMed ID: 16913697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Sclerosis and Antibodies against KIR4.1.
    Pröbstel AK; Kuhle J; Lecourt AC; Vock I; Sanderson NS; Kappos L; Derfuss T
    N Engl J Med; 2016 Apr; 374(15):1496-8. PubMed ID: 27074084
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
    Chastre A; Hafler DA; O'Connor KC
    N Engl J Med; 2016 Apr; 374(15):1495-6. PubMed ID: 27074083
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis--are we there yet?
    Amor S; Giovannoni G
    Mult Scler; 2007 Nov; 13(9):1083-5. PubMed ID: 17967836
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological markers in multiple sclerosis: tackling the missing elements.
    Rinaldi L; Gallo P
    Neurol Sci; 2005 Dec; 26 Suppl 4():S215-7. PubMed ID: 16388362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.
    O'Connor KC; Roy SM; Becker CH; Hafler DA; Kantor AB
    Dis Markers; 2006; 22(4):213-25. PubMed ID: 17124343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimyelin antibodies in multiple sclerosis.
    Mantegazza R
    N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14663868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple sclerosis. Biomarkers for deciding treatment].
    Meinl E; Voltz R
    MMW Fortschr Med; 2004 May; 146 Spec No 2():57-8. PubMed ID: 15376703
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimyelin antibodies in multiple sclerosis.
    Maguire GA
    N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14657439
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers in multiple sclerosis.
    Housley WJ; Pitt D; Hafler DA
    Clin Immunol; 2015 Nov; 161(1):51-8. PubMed ID: 26143623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biomarkers in multiple sclerosis (a review and experimental data)].
    Vorob'eva AA; Ivanova MV; Fominykh VV; Zakharova MN; Zigangirova NA; Guliaeva NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):23-31. PubMed ID: 24416809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-antibodies in multiple sclerosis: an hypothesis.
    Waegemans T
    Biomed Pharmacother; 2004 Jun; 58(5):282-5. PubMed ID: 15194163
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimyelin antibodies with no progression to multiple sclerosis.
    Pelayo R; Tintoré M; Montalban X; Rovira A; Espejo C; Reindl M; Berger T
    N Engl J Med; 2007 Jan; 356(4):426-8. PubMed ID: 17251547
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple sclerosis.
    Berger T
    Autoimmunity; 2004 Jun; 37(4):321-4. PubMed ID: 15518051
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibody Profile Emerged Years Before Multiple Sclerosis Diagnosis.
    Harris E
    JAMA; 2024 Jun; 331(22):1884. PubMed ID: 38758535
    [No Abstract]   [Full Text] [Related]  

  • 20. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
    Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.